Nerviano, Italy – 09 July 2025 – NMS Group S.p.A., the largest oncology-focused R&D organization in Italy, today announced the appointment of Mr. Victor Chu to its Board of Directors, effective immediately. Mr. Chu replaces Mr. Lincoln Pan, who has stepped down from the Board after a period of dedicated and impactful service.
“We are delighted to welcome Victor Chu to the Board of NMS Group,” said David Wong, Chairman of NMS Group. “Victor brings a wealth of experience in operational excellence, value creation, and strategic oversight. His deep knowledge of portfolio management and commitment to driving sustainable growth will be a tremendous asset as we continue advancing our mission to deliver transformative cancer therapies. At the same time, I would like to thank Lincoln for his valuable contributions during his tenure on the Board. His support and insight have been instrumental to our progress.”
Mr. Chu is a Managing Director at PAG, based in Shanghai, where he oversees operations of PAG’s private equity portfolio companies. He focuses on driving performance improvement through systems implementation, operational and financial reporting, business process optimization and other strategic initiatives.
Prior to joining PAG in 2012, Mr. Chu was a project manager at Roland Berger in Beijing, where he specialized in the consumer sector. He also worked as consultant at Advancy in Paris and Shanghai.
Mr. Chu currently serves on the Boards of Directors for Shanghai Xingyi Cinema and Food Union Europe. He holds bachelor’s degrees in economics and French language from Peking University, a master’s degree in business strategy from Sciences Po Paris, and a master’s degree in marketing from HEC Paris.
